Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Liang-Ge-San, a Classic Traditional Chinese Medicine Formula, Attenuates Lipopolysaccharide-Induced Acute Lung Injury Through Up-Regulating miR-21.

Yang H, Lu Z, Huo C, Chen Y, Cao H, Xie P, Zhou H, Liu D, Liu J, Yu L.

Front Pharmacol. 2019 Nov 14;10:1332. doi: 10.3389/fphar.2019.01332. eCollection 2019.

2.

Liang-Ge-San, a classic traditional Chinese medicine formula, attenuates acute inflammation in zebrafish and RAW 264.7 cells.

Zhou H, Cao H, Zheng Y, Lu Z, Chen Y, Liu D, Yang H, Quan J, Huo C, Liu J, Yu L.

J Ethnopharmacol. 2020 Mar 1;249:112427. doi: 10.1016/j.jep.2019.112427. Epub 2019 Nov 25.

PMID:
31778782
3.

Liang-Ge-San, a classic traditional Chinese medicine formula, protects against lipopolysaccharide-induced inflammation through cholinergic anti-inflammatory pathway.

Liu JS, Wei XD, Lu ZB, Xie P, Zhou HL, Chen YY, Ma JM, Yu LZ.

Oncotarget. 2016 Apr 19;7(16):21222-34. doi: 10.18632/oncotarget.8452.

4.

Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury.

Dai L, Zhang G, Cheng Z, Wang X, Jia L, Jing X, Wang H, Zhang R, Liu M, Jiang T, Yang Y, Yang M.

Connect Tissue Res. 2018 Nov;59(6):581-592. doi: 10.1080/03008207.2018.1439480. Epub 2018 Apr 13.

PMID:
29649906
5.

Overexpression of miR-145-5p alleviated LPS-induced acute lung injury.

Yu YL, Yu G, Ding ZY, Li SJ, Fang QZ.

J Biol Regul Homeost Agents. 2019 Jul-Aug;33(4):1063-1072.

PMID:
31353880
6.

Salidroside attenuates inflammatory response via suppressing JAK2-STAT3 pathway activation and preventing STAT3 transfer into nucleus.

Qi Z, Qi S, Ling L, Lv J, Feng Z.

Int Immunopharmacol. 2016 Jun;35:265-271. doi: 10.1016/j.intimp.2016.04.004. Epub 2016 Apr 16.

PMID:
27085677
7.

MicroRNA-326 aggravates acute lung injury in septic shock by mediating the NF-κB signaling pathway.

Wu CT, Huang Y, Pei ZY, Xi X, Zhu GF.

Int J Biochem Cell Biol. 2018 Aug;101:1-11. doi: 10.1016/j.biocel.2018.04.019. Epub 2018 May 1.

PMID:
29727715
8.

Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.

Huang Y, Huang L, Zhu G, Pei Z, Zhang W.

J Cell Physiol. 2019 May;234(5):6023-6032. doi: 10.1002/jcp.27187. Epub 2018 Dec 24.

PMID:
30584668
9.

MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.

Fu L, Zhu P, Qi S, Li C, Zhao K.

Biomed Pharmacother. 2018 Nov;107:703-711. doi: 10.1016/j.biopha.2018.08.040. Epub 2018 Aug 20.

PMID:
30138892
10.

Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.

Zhao J, Yu H, Liu Y, Gibson SA, Yan Z, Xu X, Gaggar A, Li PK, Li C, Wei S, Benveniste EN, Qin H.

Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L868-L880. doi: 10.1152/ajplung.00281.2016. Epub 2016 Sep 16.

11.

MicroRNA-21 inhibits lipopolysaccharide-induced acute lung injury by targeting nuclear factor-κB.

Zhu WD, Xu J, Zhang M, Zhu TM, Zhang YH, Sun K.

Exp Ther Med. 2018 Dec;16(6):4616-4622. doi: 10.3892/etm.2018.6789. Epub 2018 Sep 24.

12.

MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3.

Lin Y, Yang Y.

Pathol Res Pract. 2019 Apr;215(4):683-688. doi: 10.1016/j.prp.2018.12.028. Epub 2018 Dec 26.

PMID:
30600184
13.

Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.

Zhang X, Sun CY, Zhang YB, Guo HZ, Feng XX, Peng SZ, Yuan J, Zheng RB, Chen WP, Su ZR, Huang XD.

J Ethnopharmacol. 2016 Jun 20;186:91-102. doi: 10.1016/j.jep.2016.03.057. Epub 2016 Mar 30.

PMID:
27036629
14.

MiR-216a alleviates LPS-induced acute lung injury via regulating JAK2/STAT3 and NF-κB signaling.

Kong F, Sun Y, Song W, Zhou Y, Zhu S.

Hum Cell. 2020 Jan;33(1):67-78. doi: 10.1007/s13577-019-00289-7. Epub 2019 Nov 29.

PMID:
31784954
15.

Elevated IL-33 promotes expression of MMP2 and MMP9 via activating STAT3 in alveolar macrophages during LPS-induced acute lung injury.

Liang Y, Yang N, Pan G, Jin B, Wang S, Ji W.

Cell Mol Biol Lett. 2018 Oct 31;23:52. doi: 10.1186/s11658-018-0117-x. eCollection 2018.

16.

Lysimachia clethroides Duby extract attenuates inflammatory response in Raw 264.7 macrophages stimulated with lipopolysaccharide and in acute lung injury mouse model.

Shim DW, Han JW, Sun X, Jang CH, Koppula S, Kim TJ, Kang TB, Lee KH.

J Ethnopharmacol. 2013 Dec 12;150(3):1007-15. doi: 10.1016/j.jep.2013.09.056. Epub 2013 Oct 18.

PMID:
24145006
17.

[Calenduloside E inhibits lipopolysaccharide-induced inflammatory response by inhibiting activation of ROS-mediated JAK1-stat3 signaling pathway in RAW264.7 cells].

Tang T, Wang S, Cai T, Cheng Z, Qi S, Qi Z.

Nan Fang Yi Ke Da Xue Xue Bao. 2019 Aug 30;39(8):904-910. doi: 10.12122/j.issn.1673-4254.2019.08.05. Chinese.

PMID:
31511209
18.

Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.

Qiushi W, Guanghua L, Guangquan X.

Eur J Pharmacol. 2015 Mar 5;750:32-8. doi: 10.1016/j.ejphar.2015.01.023. Epub 2015 Jan 23.

PMID:
25620130
19.

The ability to suppress macrophage-mediated inflammation in orbital fat stem cells is controlled by miR-671-5p.

Lien GS, Liu JF, Chien MH, Hsu WT, Chang TH, Ku CC, Ji AT, Tan P, Hsieh TL, Lee LM, Ho JH.

Stem Cell Res Ther. 2014 Aug 13;5(4):97. doi: 10.1186/scrt486.

20.

Supplemental Content

Support Center